Agent Capital
Overview
Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs . From preclinical to commercial, they make direct equity investments across all stages of development . The firm aligns with scientists, entrepreneurs, and other investors to develop the next generation of healthcare innovations that will have a positive impact on patients' lives . Their key investment areas include rare diseases, oncology, neurology, and immunology .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Metagenomi | Apr 2021 | Series A Extension | Co-investor |
| Mediar Therapeutics | Mar 2021 | Seed | - |
| Palvella Therapeutics | Jan 2023 | Series D | - |
| Flare Therapeutics | Jun 2026 | Series C | Co-investor |
| Sesen | Mar 2023 | Reverse Merger | Co-investor |
For institutional investors. Book with your work email.
Key People
Geeta Vemuri
Founder and Managing Partner
Preston Noon
General Partner, Co-Founder
John Glasspool
Venture Partner
John Orloff
Venture Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Agent Capital based?
Headquarters information for Agent Capital is not publicly available.
When was Agent Capital founded?
Agent Capital was founded in 2017.
How many portfolio companies does Agent Capital have?
Agent Capital has 27 portfolio companies in Caplight's dataset.
What are some companies in Agent Capital's portfolio?
Portfolio companies visible on Caplight include Metagenomi, Mediar Therapeutics, Palvella Therapeutics, Flare Therapeutics, Sesen.
What was Agent Capital's most recent investment shown here?
Agent Capital's most recent investment in this portfolio sample was in Flare Therapeutics in 2026.
What sectors does Agent Capital focus on?
Agent Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does Agent Capital focus on?
Agent Capital typically invests at the MultiStage stage.
What is Agent Capital's AUM?
Agent Capital's assets under management are estimated between $50.0M and $100.0M.